IMPACT OF SHORT- VERSUS LONG-TERM DAPT IN PATIENTS WITH DIABETES MELLITUS UNDERGOING PERCUTANEOUS INTERVENTION WITH ENDEAVOR ZOTAROLIMUS-ELUTING STENTS - A SUBANALYSIS OF THE LARGE, PROSPECTIVE, RANDOMIZED, MULTICENTER OPTIMIZE TRIAL

被引:2
|
作者
Feres, Fausto
Costa, Ricardo
Bhatt, Deepak
De Paula, Joao
Botelho, Roberto
Antonio Marin-Neto, J.
Berti, Sergio
Teixeirense, Pablo
Padilha, Rone
Sarmento-Leite, Rogerio
Korman, Adrian
Sanchez, Andres
Chaves, Aurea
Abizaid, Andrea
Abizaid, Alexandre
机构
[1] Inst Dante Pazzanese Cardiol, Sao Paulo, Brazil
[2] Cardiovasc Res Ctr, Sao Paulo, Brazil
关键词
D O I
10.1016/S0735-1097(14)61862-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2108-297
引用
收藏
页码:A1859 / A1859
页数:1
相关论文
共 50 条
  • [1] Comparison of Zotarolimus-Eluting Stents with Sirolimus-Eluting and Paclitaxel-Eluting Stents for Patients with Diabetes Mellitus in the ZEST Trial: A Subanalysis of a Randomized Trial
    Park, Jong-Sun
    Park, Duk-Woo
    Kim, Young-Hak
    Yun, Sung-Cheol
    Kang, Soo-Jin
    Lee, Seung-Whan
    Lee, Cheol Whan
    Park, Seong-Wook
    Park, Seung-Jung
    Seong, In-Whan
    Lee, Jae-Hwan
    Tahk, Seung-Jea
    Jeong, Myung-Ho
    Jang, Yangsoo
    Cheong, Sang-Sig
    Yang, Joo-Young
    Lim, Do-Sun
    Seung, Ki-Bae
    Chae, Jei Keon
    Hur, Seung-Ho
    Lee, Sang-Gon
    Yoon, Junghan
    Lee, Nae-Hee
    Choi, Young-Jin
    Kim, Hyun Sook
    Kim, Kee-Sik
    Kim, Hyo-Soo
    Hong, Taeg Jong
    Park, Hun Sik
    AMERICAN JOURNAL OF CARDIOLOGY, 2010, 105 (9A): : 67B - 67B
  • [2] STENT THROMBOSIS FOLLOWING IMPLANTATION OF ENDEAVOR ZOTAROLIMUS-ELUTING STENTS IN PATIENTS WITH COMPLEX CORONARY LESIONS - INSIGHTS FROM THE LARGE, PROSPECTIVE, RANDOMIZED, MULTICENTER OPTIMIZE TRIAL
    Costa, Ricardo A.
    Abizaid, Alexandre
    Bhatt, Deepak
    Tinoco de Paula, Joao E.
    Siqueira, Dimytri
    Devito, Fernando
    Antonio Marin-Neto, J.
    Botelho, Roberto
    Castello, Helio
    Mangione, Jose
    Meireles, George
    Centemero, Marinella
    Tanajura, Luiz
    Abizaid, Andrea
    Feres, Fausto
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A1906 - A1906
  • [3] Long-term outcome of second-generation everolimus-eluting stents and Endeavor zotarolimus-eluting stents in a prospective registry of ST-elevation myocardial infarction patients
    Velders, Matthijs A.
    Boden, Helen
    van der Hoeven, Bas L.
    Liem, Su-San
    Atary, Jael Z.
    van der Wall, Ernst E.
    Jukema, J. Wouter
    Schalij, Martin J.
    EUROINTERVENTION, 2013, 8 (10) : 1199 - 1206
  • [4] SIX MONTHS OCT OUTCOMES OF BIODEGRADABLE POLYMER BIOLIMUS-ELUTING STENTS VERSUS DURABLE POLYMER ZOTAROLIMUS-ELUTING STENTS IN PATIENTS WITH CAD: PROSPECTIVE, RANDOMIZED, MULTICENTER TRIAL
    Lee, Byoung Kwon
    Kwon, Hyuck Moon
    Yoon, Young Won
    Min, Pil-Ki
    Hong, Bum-Kee
    Hong, Myeong-Ki
    Jang, Yang Soo
    Kim, Byeong-Keuk
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E1192 - E1192
  • [5] TWENTE: A Prospective, Randomized Trial of Second-Generation Zotarolimus-Eluting Stents and Everolimus-Eluting Stents in Unselected Patients Undergoing Non-Primary Percutaneous Coronary Interventions
    von Birgelen, Clemens
    Basalus, Mounir W.
    Tandjung, Kenneth
    van Houwelingen, K. Gert
    Stoel, Martin G.
    Louwerenburg, Hans W.
    Linssen, Gerard C.
    Said, Salah A.
    Kleijne, Miep A.
    Sen, Hanim
    Loewik, M.
    Verhorst, Patrick M.
    de Man, Frits H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (20) : XV - XV
  • [6] Rationale and design of amphilimus sirolimus-eluting stents versus zotarolimus-eluting stents in all-comers requiring percutaneous coronary intervention (ReCre8): A multicenter randomized clinical trial
    Rozemeijer, Rik
    Stein, Mera
    Frambach, Peter
    Voskuil, Michiel
    Kraaijeveld, Adriaan O.
    Rodriguez-Olivares, Ramon
    Timmers, Leo
    Pereira, Bruno
    Rittersma, Saskia Z.
    Agostoni, Pierfrancesco
    Doevendans, Pieter A.
    Stella, Pieter R.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2018, 91 (03) : 410 - 416
  • [7] Long-Term Efficacy and Safety of Zotarolimus-Eluting Stent in Patients With Diabetes Mellitus: Pooled 5-year Results From the ENDEAVOR III and IV Trials
    Vardi, Moshe
    Burke, David A.
    Bangalore, Sripal
    Pencina, Michael J.
    Mauri, Laura
    Kandzari, David E.
    Leon, Martin B.
    Cutlip, Donald E.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2013, 82 (07) : 1031 - 1038
  • [9] Comparison of zotarolimus-eluting stents versus sirolimus-eluting stents versus paclitaxel-eluting stents for primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: results from the Korean Multicentre Endeavor (KOMER) acute myocardial infarction (AMI) trial
    Kang, Woong Chol
    Ahn, Taehoon
    Lee, Kyounghoon
    Han, Seung Hwan
    Shin, Eak Kyun
    Jeong, Myung Ho
    Yoon, Jung Han
    Park, Jong-Seon
    Bae, Jang Ho
    Hur, Seung Ho
    Rha, Seung Woon
    Oh, Seok Kyu
    Kim, Doo Il
    Jang, Yangsoo
    Choi, Jae Woong
    Kim, Byung Ok
    EUROINTERVENTION, 2011, 7 (08) : 936 - 943
  • [10] Differential long-term outcomes of zotarolimus-eluting stents compared with sirolimus-eluting and paclitaxel-eluting stents in diabetic and nondiabetic patients: Two-year subgroup analysis of the ZEST randomized trial
    Jang, Sun-Joo
    Park, Duk-Woo
    Kim, Won-Jang
    Kim, Young-Hak
    Yun, Sung-Cheol
    Kang, Soo-Jin
    Lee, Seung-Whan
    Lee, Cheol Whan
    Park, Seong-Wook
    Park, Seung-Jung
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2013, 81 (07) : 1106 - 1114